Hoya Corp. (OTCMKTS:HOCPY – Get Free Report)’s share price fell 5% on Tuesday. The stock traded as low as $156.86 and last traded at $157.0825. 391 shares were traded during mid-day trading, a decline of 99% from the average session volume of 39,077 shares. The stock had previously closed at $165.3350.
Analysts Set New Price Targets
Separately, Zacks Research raised Hoya from a “hold” rating to a “strong-buy” rating in a report on Wednesday, September 30th. One research analyst has rated the stock with a Strong Buy rating. Based on data from MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.
Read Our Latest Stock Report on Hoya
Hoya Trading Up 0.0%
The firm’s 50-day simple moving average is $155.28 and its 200-day simple moving average is $166.07. The firm has a market capitalization of $52.54 billion, a PE ratio of 29.77, a price-to-earnings-growth ratio of 3.51 and a beta of 0.97. The company has a quick ratio of 4.20, a current ratio of 4.91 and a debt-to-equity ratio of 0.03.
Hoya (OTCMKTS:HOCPY – Get Free Report) last announced its quarterly earnings results on Friday, October 30th. The technology company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.05. Hoya had a net margin of 27.58% and a return on equity of 25.78%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Equities analysts expect that Hoya Corp. will post 5.27 earnings per share for the current year.
About Hoya
HOYA Corporation is a Japan-based technology and healthcare company that develops and manufactures optical products and precision components. Founded in 1941 as an optical glass manufacturer, the company has expanded into medical devices, vision care, and advanced technologies used in semiconductor production and other industrial applications.
Through its Life Care businesses, HOYA provides prescription eyeglass lenses, contact lenses, intraocular lenses used in cataract surgery, and medical equipment such as endoscopic systems.
Read More
- Five stocks we like better than Hoya
- Alphabet’s Golden Dome Talks Could Open a New Market, But How Much Is at Stake?
- Tempus AI Surges on Earnings Beat, But Can the Rally Last?
- MicroVision Pivots: Mapping New Ground Beyond Auto
- Are the Fears Around Alphabet’s Search Slowdown Warranted?
Receive News & Ratings for Hoya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoya and related companies with MarketBeat.com's FREE daily email newsletter.
